Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) shareholders (or potential shareholders) will be happy to see that the CEO & Executive Director, Shaojun Chen, recently bought a whopping HK$5.8m worth of stock, at a price of HK$1.10. That purchase boosted their holding by 53%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.

See our latest analysis for Dawnrays Pharmaceutical (Holdings)

The Last 12 Months Of Insider Transactions At Dawnrays Pharmaceutical (Holdings)

In fact, the recent purchase by Shaojun Chen was the biggest purchase of Dawnrays Pharmaceutical (Holdings) shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was higher than HK$1.01 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. We always take careful note of the price insiders pay when purchasing shares. Generally speaking, it catches our eye when insiders have purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.

While Dawnrays Pharmaceutical (Holdings) insiders bought shares during the last year, they didn't sell. They paid about HK$1.21 on average. I'd consider this a positive as it suggests insiders see value at around the current price. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

Dawnrays Pharmaceutical (Holdings) is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Does Dawnrays Pharmaceutical (Holdings) Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Dawnrays Pharmaceutical (Holdings) insiders own 13% of the company, worth about HK$209m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The Dawnrays Pharmaceutical (Holdings) Insider Transactions Indicate?

The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. Once you factor in the high insider ownership, it certainly seems like insiders are positive about Dawnrays Pharmaceutical (Holdings). One for the watchlist, at least! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Dawnrays Pharmaceutical (Holdings). You'd be interested to know, that we found 2 warning signs for Dawnrays Pharmaceutical (Holdings) and we suggest you have a look.